nexviadyme
sanofi b.v. - avalglucosidase alfa - glycogen opbevaring sygdom type ii - andre alimentary tract and metabolism produkter, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).
briotril 400 ec emulsionskoncentrat
adama northern europe b.v. - ioxynil, bromoxynil - emulsionskoncentrat - 160 g/l ioxynil ; 240 g/l bromoxynil
tilt 250 ec emulsionskoncentrat
syngenta nordics a/s - propiconazol - emulsionskoncentrat - 250 g/l propiconazol
duotril 400 ec emulsionskoncentrat
adama northern europe b.v. - ioxynil, bromoxynil - emulsionskoncentrat - 160 g/l ioxynil ; 240 g/l bromoxynil
pantecta control
takeda gmbh - pantoprazol - gastroøsofageal tilbagesvaling - proton pumpe hæmmere - kortvarig behandling af reflukssymptomer (f.eks. halsbrand, syreregurgitation) hos voksne.
preotact
nps pharma holdings limited - parathyroidhormon (rdna) - osteoporose, postmenopausale - calciumhomeostase - behandling af osteoporose hos postmenopausale kvinder med stor risiko for brud (se afsnit 5. en signifikant reduktion i forekomsten af vertebrale, men ikke hoftefrakturer er blevet påvist.
finy vanddispergerbart granulat
agrichem b. v. - metsulfuron-methyl, metsulfuron - vanddispergerbart granulat - 200 g/kg metsulfuron-methyl ; (~ 193 g/kg metsulfuron
agros pyraclostrobin emulsionskoncentrat
agros - pyraclostrobin - emulsionskoncentrat - 250 g/l pyraclostrobin
xylocain 5% kutanopløsning
aspen pharma trading limited - lidocain - kutanopløsning - 5%